"immune checkpoint inhibitors therapy" trang 4 - tải miễn phí từ tailieunhanh
Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer

Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer
9    25    1
Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer

Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer
19    23    1
Construction and validation of an immune infltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

Construction and validation of an immune infltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma
18    1    1
A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer

A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer
12    3    1
Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
21    4    1
Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?

Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?
9    1    1
Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: Study protocol for a randomized phase Ib/IIa trial

Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: Study protocol for a randomized phase Ib/IIa trial
11    1    1
Association between the efcacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: A retrospective study

Association between the efcacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: A retrospective study
10    1    1
Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: A case report

Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: A case report
8    22    1
Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitorrelated pneumonitis

Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitorrelated pneumonitis
9    17    1
TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients

TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients
11    4    1
Case report: Reinitiating pembrolizumab treatment after small bowel perforation

Case report: Reinitiating pembrolizumab treatment after small bowel perforation
9    87    0
The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma

The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma
11    77    1
Immunotherapy and associated immunerelated adverse events at a large UK centre: A mixed methods study

Immunotherapy and associated immunerelated adverse events at a large UK centre: A mixed methods study
11    78    1
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy
11    47    1
Systematic profiling of diagnostic and prognostic value of autophagy-related genes for sarcoma patients

Systematic profiling of diagnostic and prognostic value of autophagy-related genes for sarcoma patients
10    25    1
IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: A case report

IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: A case report
5    59    1
Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer

Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer
19    56    1
Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response

Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response
12    29    1
Association of advanced age and cancer history with autoimmune disease in melanoma patients: A cross-sectional study

Association of advanced age and cancer history with autoimmune disease in melanoma patients: A cross-sectional study
8    55    3